Orexins: Neuropeptides for all seasons and functions

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 4, 2006, Pages

  Levin, Barry E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; SECRETIN;

AMINO ACID SEQUENCE; CELL POPULATION; CENTRAL NERVOUS SYSTEM; DIET RESTRICTION; EDITORIAL; ENERGY BALANCE; FEEDBACK SYSTEM; FEEDING; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUNGER; HYPOTHALAMUS; INGESTION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY;

ANIMALS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES;

EID: 33749319936     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00344.2006     Document Type: Editorial

References (60)

1. Anand BK, Chhina GS, Sharma KN, Dua S, and Singh B. Activity of single neurons in the hypothalamus feeding centers: effect of glucose. Am J Physiol 207: 1146-1154, 1964.
2. Backberg M, Hervieu G, Wilson S, and Meister B. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 15: 315-328, 2002.
3. Bayer L, Colard C, Nguyen NU, Risold PY, Fellmann D, and Griffond B. Alteration of the expression of the hypocretin (orexin) gene by 2-deoxyglucose in the rat lateral hypothalamic area. Neuroreport 11: 531-533, 2000.
4. Broberger C, De Lecea L, Sutcliffe JG, and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402: 460-474, 1998.
5. Burdakov D, Gerasimenko O, and Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci 25: 2429-2433, 2005.
6. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, Tadayyon M, Clapham JC, Wilding J, and Williams G. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48: 2132-2137, 1999.
7. Clegg DJ, Benoit SC, Reed JA, Woods SC, and Levin BE. Reduced anorexic effects of insulin in obesity-prone rats and rats fed a moderate fat diet. Am J Physiol Regul Integr Comp Physiol 288: R981-R986, 2005.
8. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, and Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748-753, 1999.
9. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, and Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
10. Dube MG, Horvath TL, Kalra PS, and Kalra SP. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides 21: 1557-1560, 2000.
11. Elias CF and Bittencourt JC. Study of the origins of melanin- concentrating hormone and neuropeptide EI immunoreactive projections to the periaqueductal gray matter. Brain Res 755: 255-271, 1997.
12. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, and Elmquist JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459, 1998.
13. Ford ES, Giles WH, and Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449, 2004.
14. Fu LY, Acuna-Goycolea C, and van den Pol AN. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24: 8741-8751, 2004.
15. Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, Dopazo A, Bloom FE, and Sutcliffe JG. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93: 8733-8738, 1996.
16. Griffond B, Risold PY, Jacquemard C, Colard C, and Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 262: 77-80, 1999.
17. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345-354, 2001.
18. Harthoorn LF, Sane A, Nethe M, and Van Heerikhuize JJ. Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol 25: 1209-1223, 2005.
19. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, and Arch JR. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 96: 45-51, 2000.
20. Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Taddayon M, and Arch JRS. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20: 1099-1105, 1999.
21. Horvath TL, Diano S, and van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19: 1072-1087, 1999.
22. Iqbal J, Pompolo S, Murakami T, Grouzmann E, Sakurai T, Meister B, and Clarke IJ. Immunohistochemical characterization of localization of long-form leptin receptor (OB-Rb) in neurochemically defined cells in the ovine hypothalamus. Brain Res 920: 55-64, 2001.
23. Keesey RE and Corbett SW. Metabolic defense of the body weight set-point. In: Eating and Its Disorders (62nd ed.), edited by Stunkard AJ and Stellar E. New York: Raven, 1984, p. 87-96.
24. Kotz CM, Teske JA, Levine JA, and Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 104: 27-32, 2002.
25. Levin BE and Dunn-Meynell A. A reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283: R941-R948, 2002.
26. Levin BE, Dunn-Meynell AA, Balkan B, and Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 273: R725-R730, 1997.
27. Levin BE, Dunn-Meynell AA, and Banks WA. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling prior to obesity onset. Am J Physiol Regul Integr Comp Physiol 286: R143-R150, 2004.
28. Levin BE, Dunn-Meynell AA, McMinn JE, Cunningham-Bussel A, and Chua SC Jr. A new obesity-prone, glucose intolerant rat strain (F. DIO). Am J Physiol Regul Integr Comp Physiol 285: R1184-R1191, 2003.
29. Levin BE, Routh VH, Kang L, Sanders NM, and Dunn-Meynell A. A neuronal glucosensing: What do we know after 50 years? Diabetes 53: 2521-2528, 2004.
30. Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR, Kane PH, Jensen MD, and Clark MM. Interindividual variation in posture allocation: possible role in human obesity. Science 307: 584-586, 2005.
31. Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, Senaris R, and Dieguez C. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 269: 41-45, 2000.
32. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, and Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6-25, 2001.
33. 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci 19: 1524-1534, 2004.
34. 2+ in orexin neurons of the rat lateral hypothalamus. Neurosci Lett 309: 165-168, 2001.
35. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, and Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 873: 181-187, 2000.
36. Neel V. In diabetes mellitus: a "thrifty" genotype rendered detrimental by progress. Am J Hum Genet 14: 353-362, 1962.
37. Oomura Y, Kimura K, Ooyama H, Maeo T, Iki M, and Kuniyoshi N. Reciprocal activities of the ventromedial and lateral hypothalamic area of cats. Science 143: 484-485, 1964.
38. Oomura Y, Nakamura T, Sugimori M, and Yamada Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol Behav 14: 483-486, 1975.
39. Peyron C, Tighe DK, van den Pol AN, De Lecea L, Heller HC, Sutcliffe JG, and Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
40. Puthuraya KP, Oomura Y, and Shimizu N. Effects of endogenous sugar acids on the ventromedial hypothalamic nucleus of the rat. Brain Res 332: 165-168, 1985.
41. Sahu A. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Brain Res 944: 232-238, 2002.
42. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
43. Seeley RJ, Payne CJ, and Woods SC. Neuropeptide Y fails to increase intraoral intake in rats. Am J Physiol Regul Integr Comp Physiol 268: R423-R427, 1995.
44. Sergeyev V, Broberger C, Gorbatyuk O, and Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 11: 117-121, 2000.
45. Song Z, Levin BE, McArdle JJ, Bakhos N, and Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus (VMN). Diabetes 50: 2673-2681, 2001.
46. Song Z and Routh VH. Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 54: 15-22, 2005.
47. Stellar E. The physiology of motivation. Psychol Rev 5: 5-22, 1954.
48. Teske JA, Levine AS, Kuskowski M, Levine JA, and Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 291: R889-R899, 2006.
49. Thorpe AJ and Kotz CM. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res 1050: 156-162, 2005.
50. Tritos NA, Mastaitis JW, Kokkotou E, and Maratos-Flier E. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res 895: 160-166, 2001.
51. Tritos NA, Vicent D, Gillette J, Ludwig DS, Flier ES, and Maratos-Flier E. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus. Diabetes 47: 1687-1692, 1998.
52. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, and Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75, 1998.
53. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19: 3171-3181, 1999.
54. Van Den Top M, Lee K, Whyment AD, Blanks AM, and Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 7: 493-494, 2004.
55. Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero V, and Routh VH. The effects of oleic-acid (OA) on distinct populations of neurons in the hypothalamic arcuate nucleus (ARC) are dependent on extracellular glucose levels. J Neurophysiol 95: 1491-1498, 2006.
56. Wang R, Liu X, Dunn-Meynell AA, Levin BE, and Routh VH. The regulation of glucose-excited (GE) neurons in the hypothalamic arcuate nucleus by glucose and feeding relevant peptides. Diabetes 53: 1959-1965, 2004.
57. Wang Y. Cross-national comparison of childhood obesity: the epidemic and the relationship between obesity and socioeconomic status. Int J Epidemiol 30: 1129-1136, 2001.
58. Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, Miwa Y, Goto K, and Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 859: 404-409, 2000.
59. Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, and Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849: 248-252, 1999.
60. Yang X, Kow LM, Funabashi T, and Mobbs CV. Hypothalamic glucose sensor. Similarities to and differences from pancreatic β-cell mechanisms. Diabetes 48: 1763-1772, 1999.